Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by RealScientiston Apr 29, 2016 3:06pm
219 Views
Post# 24826773

RE:What if Warrants Don't Get Exercised?

RE:What if Warrants Don't Get Exercised?
DoubleDown123 wrote: If warrants in June don't get exercised, PP will be needed and at what price will that be. I don't see share price rising above 50 cents for 10 straight trading days before June a t this point, especially with absolutely no help from IR firm. Thoughts?


The only way we get the stock price over 60 cents is if we start getting news releases. I'm stunned that it's been a week since release of TWO quarterly financials where we saw significant growth QOQ and not a single word from the company. I don't know, or understand the reason for this. Nor do I know who is to blame for the poor communication. People are saying it's not Arun's fault as he is doing his job running the company and moving it forward. But maybe Arun is trying to hold this back and it is by design. Others are saying it's HT/Core's fault for not doing their job as IR. Until someone talks to management and gets an explanation everything is speculation. The AGM will be telling IMO if we don't see news before then. Unless there is a big news release (multiple releases or a major summary of the coming year for Vanc) with a summary of financials, big purchase orders, new molecules/OTCs, etc we're not moving anywhere but down. The AGM is June 22, which is well after the expiry on the warrants. 

The only upside is that the company has said in financials that they have enough operating money for the next 12 months so a PP is unlikely. By the time they run out of money, there will be another two financial statements where they should be near break even or profit. So really, there's almost no way they do another PP unless it has been planned all along. But really, I don't see shareholders supporting it with the stuff going on right now to hold this back. 

Let's hope for news in the coming weeks. If they want those warrants exercised, they better get on it. There's only about 25 trading days left so they have three weeks to release something substantial. 
Bullboard Posts